Updates in the Management of Renal Cell Carcinoma

At JADPRO Live Virtual 2021, advanced practitioner experts reviewed clinical updates in the treatment of renal cell carcinoma, key patient counseling and monitoring considerations, and best practices to manage adverse events associated with therapies for renal cell carcinoma.

Detalles Bibliográficos
Autores principales: Hanna, Kirollos S., Lim, Zita D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126346/
https://www.ncbi.nlm.nih.gov/pubmed/35663157
http://dx.doi.org/10.6004/jadpro.2022.13.3.27
Descripción
Sumario:At JADPRO Live Virtual 2021, advanced practitioner experts reviewed clinical updates in the treatment of renal cell carcinoma, key patient counseling and monitoring considerations, and best practices to manage adverse events associated with therapies for renal cell carcinoma.

Ejemplares similares